Exclusive: What Really Drove 23andMe And The FDA Apart
Is getting a $99 DNA test really hazardous to your health? Our editor-in-chief decodes an innovation dustup.
When we put 23andMe CEO Anne Wojcicki on the cover of Fast Company's November issue, we didn't expect the FDA to yank the company's $99 DNA test off the market a few weeks later. Yet there's a reason we called Wojcicki "the most daring CEO in America": Her company's product challenges established conventions about medical practices, research, insurance, and more. So is that challenge at the heart of the FDA's rebuke? Or did something more basic derail Wojcicki's mission?
No comments have been added yet.
David Lidsky's Blog
- David Lidsky's profile
- 3 followers
David Lidsky isn't a Goodreads Author
(yet),
but they
do have a blog,
so here are some recent posts imported from
their feed.
